Roivant Sciences

ROIV

3 Followers

$10.64

-3.54%

-$0.39

29 May

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

ROIV Fair Price

$3.48

Overvalued by 93.7%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Roivant Sciences (ROIV) is a biotechnology company specializing in the development and commercialization of innovative drugs and therapies. Utilizing advanced technologies and a strategic approach to research and development, Roivant Sciences focuses on rapidly bringing new treatment options to market. The company is known for its unique model and portfolio, which includes various therapeutic areas. Roivant Sciences is also engaged in partnerships with other organizations to accelerate healthcare innovations. Roivant Sciences (ROIV) shares could be suitable for investors looking for opportunities in the biotechnology sector with a focus on innovation and research.